Nomura Q1 FY2027 Net Income Surges 39% to ¥145.6B on Broad-Based Strength
NMR sits 48% above its 52-week low of $6.71.
Summary
Nomura reported Q1 FY2027 net income of ¥145.6 billion, a 39% increase year-on-year, with all major business segments delivering strong growth. The results underscore the firm's successful execution of its strategic priorities and integration of the Macquarie asset management acquisition.
Key Events · Earnings and Guidance · NMR
-
Net Income Up 39% to ¥145.6B
Q1 FY2027 net income attributable to NHI shareholders rose to ¥145.6 billion from ¥104.8 billion a year earlier, driven by revenue growth across all segments.
-
Revenue Growth Outpaces Expenses
Net revenue increased 31.2% to ¥686.7 billion, while non-interest expenses rose 30.9% to ¥475.2 billion, resulting in a 32% increase in pre-tax income to ¥211.5 billion.
-
Investment Management Revenue Nearly Doubles
Investment Management net revenue surged 94.4% to ¥98.3 billion, reflecting the consolidation of the Macquarie acquisition and strong business revenue growth.
-
Wholesale Equities Revenue Jumps 83%
Wholesale net revenue rose 41.4% to ¥369.1 billion, with Equities revenue up 82.6% to ¥179.5 billion on strong performance in equity products.
Analysis · NMR · Finance
Nomura delivered a standout quarter with net income up 39% year-on-year to ¥145.6 billion, driven by record performances across Wealth Management, Investment Management, and Wholesale. Revenue growth of 31% outpaced expense growth of 31%, lifting pre-tax income 32%. The Investment Management segment nearly doubled revenue following the Macquarie acquisition, while Wholesale benefited from a surge in Equities. Capital ratios remain solid with a CET1 ratio of 12.9%, and assets under management jumped 14% to ¥156.4 trillion. The results reinforce the firm's upward trajectory after a record full-year performance and ambitious 2030 targets set in May.
At the time of this filing, NMR was trading at $9.90 on NYSE in the Finance sector, with a market capitalization of approximately $28.4B. The 52-week trading range was $6.71 to $10.06. This filing was assessed with positive market sentiment and an importance score of 8 out of 10.